TABLE 1.
Characteristics of potentially suitable donor referrals with at least one perceived cancer
| Characteristics | Declined for donation | Accepted for donation | Overall | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verified unsuitable | Verified suitable | Total | Verified unsuitable | Verified suitable | Total | P a | |||||||||
| Missed opportunities | Excess-risk donors | ||||||||||||||
| N (row %) | 94 | (60) | 38 | (24) | 132 | (85) | 5 | (3) | 19 | (12) | 24 | (15) | 156 | (100) | |
| Age, median (IQR) | 61.5 | (50–71) | 67 | (51–71) | 63 | (51–72) | 61 | (60–62) | 61 | (54–64) | 61 | (56–63.5) | 62 | (52–71) | 0.5 |
| Female | 41 | (44) | 19 | (50) | 60 | (45) | 3 | (60) | 6 | (32) | 9 | (38) | 69 | (44) | 0.5 |
| Comorbidities, mean (SD) | 0.8 | (0.96) | 0.9 | (1.11) | 0.8 | (1.00) | 1.2 | (1.10) | 2.1 | (1.15) | 1.9 | (1.18) | 1.0 | (1.10) | <0.001 |
| Hypertension | 17 | (18) | 9 | (24) | 26 | (20) | 0 | (0) | 9 | (47) | 9 | (38) | 35 | (22) | |
| Hyperlipidemia | 4 | (4) | 1 | (3) | 5 | (4) | 2 | (40) | 9 | (47) | 11 | (46) | 16 | (10) | |
| Chronic liver disease | 0 | (0) | 0 | (0) | 0 | (0) | 0 | (0) | 1 | (5) | 1 | (4) | 1 | (<1) | |
| Chronic kidney disease | 4 | (4) | 2 | (5) | 6 | (5) | 1 | (20) | 2 | (11) | 3 | (13) | 9 | (6) | |
| Diabetes (T1 or T2) | 5 | (5) | 5 | (13) | 10 | (8) | 0 | (0) | 5 | (26) | 5 | (21) | 15 | (10) | |
| Respiratory disease | 10 | (11) | 3 | (8) | 13 | (10) | 1 | (20) | 5 | (26) | 6 | (25) | 19 | (12) | |
| Infection | 11 | (12) | 7 | (18) | 18 | (14) | 0 | (0) | 1 | (5) | 1 | (4) | 19 | (12) | |
| Ischemic heart disease | 20 | (21) | 7 | (18) | 27 | (20) | 2 | (40) | 8 | (42) | 10 | (42) | 37 | (24) | |
| Perceived risk | <0.001 | ||||||||||||||
| Not contraindicated | 2 | (2) | 2 | (5) | 4 | (3) | 3 | (60) | 16 | (84) | 19 | (79) | 23 | (15) | |
| Minimal risk (<0.1%) | 0 | (0) | 0 | (0) | 0 | (0) | 0 | (0) | 2 | (11) | 2 | (8) | 2 | (1) | |
| Low risk (0.1%–2%) | 1 | (1) | 3 | (8) | 4 | (3) | 1 | (20) | 1 | (5) | 2 | (8) | 6 | (4) | |
| Intermediate risk (2%–10%) | 9 | (10) | 1 | (3) | 10 | (8) | 0 | (0) | 0 | (0) | 0 | (0) | 10 | (6) | |
| High risk (>10%) | 11 | (12) | 6 | (16) | 17 | (13) | 0 | (0) | 0 | (0) | 0 | (0) | 17 | (11) | |
| Contraindicated | 71 | (76) | 26 | (68) | 97 | (73) | 1 | (20) | 0 | (0) | 1 | (4) | 98 | (63) | |
aP values calculated using Wilcoxon rank-sum test for age, comorbidities, and perceived risk and Fisher exact test for sex.